Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil's lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific ...

Lung Cancer Screening An NHS initiative, which remains successful in Lancashire and Cumbria, is set to invite Preston’s people ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.